FA
AGN

Fortis Advisors’s Allergan plc AGN Stock Holding History

Fortis Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-290
Closed -$49K – 374
2019
Q2 		$49K Hold
290
– – 0.02% 233
2019
Q1 		$42K Sell
290
-40
-12% -$5.8K 0.02% 233
2018
Q4 		$44K Hold
330
– – 0.03% 223
2018
Q3 		$63K Hold
330
– – 0.04% 189
2018
Q2 		$55K Buy
330
+290
+725% +$46.6K 0.03% 197
2018
Q1 		$7K Hold
40
– – ﹤0.01% 271
2017
Q4 		$7K Hold
40
– – ﹤0.01% 251
2017
Q3 		$8K Sell
40
-1,817
-98% -$423K 0.01% 245
2017
Q2 		$451K Hold
1,857
– – 0.35% 33
2017
Q1 		$444K Buy
+1,857
New +$432K 0.4% 28

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fortis Advisors's AGN Position: Q3 2019 in Review

Fortis Advisors sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 290 shares — an estimated $49K sold.

Fortis Advisors first reported a position in AGN in Q1 2017 and held it in 10 quarters. The position peaked at $451K in Q2 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Fortis Advisors reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Fortis Advisors sold 290 Allergan plc shares in Q3 2019, an estimated $49K.
  • Fortis Advisors first reported a position in Allergan plc in Q1 2017 and held it in 10 quarters.
  • Fortis Advisors's Allergan plc position peaked at $451K in Q2 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Fortis Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.